Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company‚Äôs equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportFiling
2022-02-14
4:41 pm
Unchanged
13GClene Inc.
CLNN
Walton Thomas Layton0
0%
0
(Unchanged)
View
2022-02-14
4:13 pm
Sale
13GTenaya Therapeutics, Inc.
TNYA
Walton Thomas Layton0
0%
-3,759,599decrease
(Position Closed)
View
2022-02-14
4:09 pm
Sale
13GBiomX Inc.
PHGE
Walton Thomas Layton0
0%
-5,512,846decrease
(Position Closed)
View
2022-02-14
4:02 pm
Sale
13GTenaya Therapeutics, Inc.
TNYA
Walton Thomas Layton0
0%
-2,642,285decrease
(Position Closed)
View
2022-02-14
3:59 pm
Sale
13GFinch Therapeutics Group, Inc.
FNCH
Walton Thomas Layton0
0%
-3,487,168decrease
(Position Closed)
View
2021-08-09
5:12 pm
Purchase
13GTenaya Therapeutics, Inc.
TNYA
Walton Thomas Layton2,642,285
6.76%
2,642,285increase
(New Position)
View
2021-08-09
4:27 pm
Purchase
13GBiomX Inc.
PHGE
Walton Thomas Layton5,512,846
17.8%
5,512,846increase
(New Position)
View
2021-03-26
4:47 pm
Purchase
13GFinch Therapeutics Group, Inc.
FNCH
Walton Thomas Layton3,487,168
7.4%
3,487,168increase
(New Position)
View
2021-01-15
3:40 pm
Purchase
13GClene Inc.
CLNN
Walton Thomas Layton3,759,599
6.3%
3,759,599increase
(New Position)
View